Unknown

Dataset Information

0

Non-invasive, vagus nerve stimulation to reduce ileus after colorectal surgery: protocol for a feasibility trial with nested mechanistic studies.


ABSTRACT:

Introduction

Ileus is a common and distressing condition characterised by gut dysfunction after surgery. While a number of interventions have aimed to curtail its impact on patients and healthcare systems, ileus is still an unmet challenge. Electrical stimulation of the vagus nerve is a promising new treatment due to its role in modulating the neuro-immune axis through a novel anti-inflammatory reflex. The protocol for a feasibility study of non-invasive vagus nerve stimulation (nVNS), and a programme of mechanistic and qualitative studies, is described.

Methods and analysis

This is a participant-blinded, parallel-group, randomised, sham-controlled feasibility trial (IDEAL Stage 2b) of self-administered nVNS. One hundred forty patients planned for elective, minimally invasive, colorectal surgery will be randomised to four schedules of nVNS before and after surgery. Feasibility outcomes include assessments of recruitment and attrition, adequacy of blinding and compliance to the intervention. Clinical outcomes include bowel function and length of hospital stay. A series of mechanistic substudies exploring the impact of nVNS on inflammation and bowel motility will inform the design of the final stimulation schedule. Semistructured interviews with participants will explore experiences and perceptions of the intervention, while interviews with patients who decline participation will explore barriers to recruitment.

Ethics and dissemination

The protocol has been approved by the Tyne and Wear South National Health Service (NHS) Research Ethics Committee (19/NE/0217) on 2 July 2019. Feasibility, mechanistic and qualitative findings will be disseminated to national and international partners through peer-reviewed publications, academic conferences, social media channels and stakeholder engagement activities. The findings will build a case for or against progression to a definitive randomised assessment as well as informing key elements of study design.

Trial registration number

ISRCTN62033341.

SUBMITTER: Chapman SJ 

PROVIDER: S-EPMC8296772 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7524862 | biostudies-literature
| S-EPMC6146235 | biostudies-literature
| S-EPMC10777229 | biostudies-literature
| S-EPMC8611055 | biostudies-literature
| S-EPMC10841711 | biostudies-literature
| S-EPMC9281624 | biostudies-literature
| S-EPMC10666166 | biostudies-literature
| S-EPMC7757623 | biostudies-literature
| S-EPMC10512834 | biostudies-literature
| S-EPMC6755582 | biostudies-other